Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yvan Jamilloux

Showing results (131-140 of 152) with videos related to

Pageof 16
Sort By:
Ophthalmology|June 8, 2025
Corticosteroids with or without Conventional Disease-Modifying Antirheumatic Drug as First-Line Therapy in Nonanterior Sarcoidosis UveitisRobin Jacquot, Pascal Sève, Guillaume Mulier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 23, 2026
A multifaceted interplay between hemophagocytosis, IL-18 and type I IFN distinguishes Still disease from other autoinflammatory diseasesYvonne M Mueller, Charlotte Girard, Harmen J G van de Werken, et al.
Rheumatology (Oxford, England)|October 18, 2017
Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasomeYvan Jamilloux, Lucie Lefeuvre, Flora Magnotti, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 2, 2020
Efficacy and safety of TNF antagonists in ocular sarcoidosis: data from the French registry STATAlicia Marquet, Catherine Chapelon-Abric, Delphine Maucort-Boulch, et al.
Cell Reports|October 12, 2022
Steroid hormone catabolites activate the pyrin inflammasome through a non-canonical mechanismFlora Magnotti, Daria Chirita, Sarah Dalmon, et al.
Frontiers in Cellular and Infection Microbiology|November 15, 2023
Hyper-inflammatory profile and immunoparalysis in patients with severe Legionnaires' diseaseCamille Allam, William Mouton, Hugo Testaert, et al.
Autoimmunity Reviews|July 8, 2021
Cardiovascular outcome in adult-onset Kawasaki diseaseElise Peter, Jean-Baptiste Fraison, Brahim Harbaoui, et al.
Seminars in Arthritis and Rheumatism|April 11, 2017
Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patientsYvan Jamilloux, Fleur Cohen-Aubart, Catherine Chapelon-Abric, et al.
American Journal of Ophthalmology|May 22, 2017
ReplyAudrey de Parisot, Yvan Jamilloux, Laurent Kodjikian, et al.
Plos One|February 15, 2020
Evaluating the cost-consequence of a standardized strategy for the etiological diagnosis of uveitis (ULISSE study)Audrey de Parisot, Yvan Jamilloux, Laurent Kodjikian, et al.
Pageof 16

Showing results (131-140 of 152) with videos related to

Sort By:
Pageof 16
Ophthalmology|June 8, 2025
Corticosteroids with or without Conventional Disease-Modifying Antirheumatic Drug as First-Line Therapy in Nonanterior Sarcoidosis UveitisRobin Jacquot, Pascal Sève, Guillaume Mulier, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 23, 2026
A multifaceted interplay between hemophagocytosis, IL-18 and type I IFN distinguishes Still disease from other autoinflammatory diseasesYvonne M Mueller, Charlotte Girard, Harmen J G van de Werken, et al.
Rheumatology (Oxford, England)|October 18, 2017
Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasomeYvan Jamilloux, Lucie Lefeuvre, Flora Magnotti, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 2, 2020
Efficacy and safety of TNF antagonists in ocular sarcoidosis: data from the French registry STATAlicia Marquet, Catherine Chapelon-Abric, Delphine Maucort-Boulch, et al.
Cell Reports|October 12, 2022
Steroid hormone catabolites activate the pyrin inflammasome through a non-canonical mechanismFlora Magnotti, Daria Chirita, Sarah Dalmon, et al.
Frontiers in Cellular and Infection Microbiology|November 15, 2023
Hyper-inflammatory profile and immunoparalysis in patients with severe Legionnaires' diseaseCamille Allam, William Mouton, Hugo Testaert, et al.
Autoimmunity Reviews|July 8, 2021
Cardiovascular outcome in adult-onset Kawasaki diseaseElise Peter, Jean-Baptiste Fraison, Brahim Harbaoui, et al.
Seminars in Arthritis and Rheumatism|April 11, 2017
Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patientsYvan Jamilloux, Fleur Cohen-Aubart, Catherine Chapelon-Abric, et al.
American Journal of Ophthalmology|May 22, 2017
ReplyAudrey de Parisot, Yvan Jamilloux, Laurent Kodjikian, et al.
Plos One|February 15, 2020
Evaluating the cost-consequence of a standardized strategy for the etiological diagnosis of uveitis (ULISSE study)Audrey de Parisot, Yvan Jamilloux, Laurent Kodjikian, et al.
Pageof 16